The association between antihypertensive drug use and incidence of prostate cancer in Finland: A population-based case-control study

Cancer Causes and Control

Volumn 22, Issue 10, 2011, Pages 1445-1452

  Kemppainen, Kimmo J ^a   Tammela, Teuvo L J ^a,b   Auvinen, Anssi ^a   Murtola, Teemu J ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

Author keywords

Antihypertensive drugs; Case control; Prostatic neoplasms

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FINASTERIDE; TAMSULOSIN;

ADVANCED CANCER; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; FINLAND; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; REGISTRIES; RISK;

EID: 82955212735     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9819-3     Document Type: Article

References (14)

1. Martin RM, Vatten L, Gunnell D, Romundstad P (2010) Blood pressure and risk of prostate cancer: cohort Norway. Cancer Causes Control 21:463-472
2. Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL (2001) Hypertension, heart rate, use of antihypertensives, and incident prostate cancer. Ann Epidemiol 11:534-542 (Pubitemid 33049887)
3. George AJ, Thomas WG, Hannan RD (2010) The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10:745-759
4. Ronquist G, Rodríguez LAG, Ruigómez A et al (2004) Association between captopril, other antihypertensive drugs and risk of prostate cancer. Prostate 58:50-56 (Pubitemid 38057988)
5. Debes JD, Roberts RO, Jacobson DJ et al (2004) Inverse association between prostate cancer and the use of calcium channel blockers. Cancer Epidemiol Biomarkers Prev 13:255-259 (Pubitemid 38222557)
6. Perron L, Bairati I, Harel F, Meyer F (2004) Antihypertensive drug use and the risk of prostate cancer. Cancer Causes Control 15:535-541 (Pubitemid 39070071)
7. Rodriguez C, Jacobs EJ, Deka A (2009) Use of blood-pressure lowering medication and risk of prostate cancer in the cancer prevention study II nutrition cohort. Cancer Causes Control 20:671-679
8. Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Acta Oncol 33:365-369 (Pubitemid 24207996)
9. Martikainen J, Rajaniemi S (2002) Drug reimbursement systems in EU member states, Iceland and Norway. Helsinki, Finland: The Social Insurance Institution, Finland, Social security and health reports 54. (Available at: http://www.kela.fi/in/internet/liite.nsf/ABID/030303101726PN/$File/ Drug-reimbursement.pdf?openElement)
10. World Health Organization. ATC/DDD Index database. (Availableat http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10)
11. Ciatto S, Zappa M, Villers A, Paez A, Otto SJ, Auvinen A (2003) Contamination by opportunistic screening in the European randomized study of prostate cancer screening. BJU Int 92:97-100 (Pubitemid 38091150)
12. Jeong IG, Hwang SS, Kim HK, Ahn H, Kim CS (2010) The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population. Cancer Epidemiol Biomarkers Prev 19:371-380
13. Vyssoulis G, Karpanou E, Kyvelou SM, Vlachopoulos C, Tzamou V, Stefanadis C (2010) Prostate-specific antigen levels are associated with arterial stiffness in essential hypertensive patients. J Sex Med [Epub ahead of print]
14. Ronquist G, Frithz G, Wang YH, Lindeborg T (2009) Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer. Scand J Urol Nephrol 43:32-36